Insulin resistance surrogates and left ventricular hypertrophy in normotensive obese children

Ljiljana Bjelakovic1, Vladimir Vukovic2, Sanja Stankovic3

  • 1Department of medical science, Faculty of Sport and Physical Education, University of Nis, Nis, Serbia.

Insights

Insulin resistance, measured by the Homeostasis Model Assessment index, is linked to increased left ventricular relative wall thickness in obese children. This finding may help identify children at risk for heart remodeling.

Area of Science:

  • Pediatric Cardiology
  • Metabolic Syndrome Research
  • Cardiovascular Health in Obesity

Background:

  • The link between insulin resistance markers and cardiac structure in obese children remains under-investigated.
  • Obesity in children is associated with metabolic disturbances and cardiovascular risks.

Purpose of the Study:

  • To investigate the association between insulin sensitivity/resistance indices and left ventricular geometry in normotensive obese children.
  • To explore the utility of Homeostasis Model Assessment index (HOMA-IR) as a predictor of cardiac changes.

Main Methods:

  • Cross-sectional study of 32 normotensive obese children.
  • Echocardiography assessed left ventricular mass index and relative wall thickness.
  • HOMA-IR, serum uric acid, and TG/HDL-C ratio served as insulin resistance markers.

Main Results:

  • A significant positive correlation was found between HOMA-IR and left ventricular relative wall thickness (r=0.47, p=0.03), persisting after BMI adjustment (r=0.48, p=0.03).
  • A HOMA-IR cutoff of ≥5.51 predicted concentric remodeling with 83.33% sensitivity and 68.75% specificity.

Conclusions:

  • Elevated HOMA-IR is associated with increased left ventricular relative wall thickness in obese children.
  • HOMA-IR may serve as a valuable tool to identify obese children at risk for concentric left ventricular remodeling.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
893
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
73
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
126
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
84
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
170